7-100310398-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001004351.5(SPDYE3):c.364G>A(p.Gly122Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004351.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 6AN: 100396Hom.: 0 Cov.: 12 FAILED QC
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000705 AC: 6AN: 850920Hom.: 0 Cov.: 11 AF XY: 0.00000690 AC XY: 3AN XY: 434562
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000597 AC: 6AN: 100482Hom.: 0 Cov.: 12 AF XY: 0.0000639 AC XY: 3AN XY: 46936
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.364G>A (p.G122S) alteration is located in exon 3 (coding exon 3) of the SPDYE3 gene. This alteration results from a G to A substitution at nucleotide position 364, causing the glycine (G) at amino acid position 122 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at